2nd Circuit Vacates In FCA Case Of First Impression Over Alleged Drug Kickbacks
NEW YORK — The Second Circuit U.S. Court of Appeals vacated and remanded in part a district court’s ruling dismissing a qui tam plaintiff’s complaint alleging that Novartis Pharmaceuticals Corp. violated...To view the full article, register now.
Already a subscriber? Click here to view full article